Skip to main content
Entheon Biomedical Corp. logo

Entheon Biomedical Corp. — Investor Relations & Filings

Ticker · ENBI LEI · 894500N2J7IXCCDRWU50 CSE Professional, scientific and technical activities
Open in API
Filings indexed 243 across all filing types
Latest filing 2025-03-05 Regulatory Filings
Country CA Canada
Listing CSE ENBI

About Entheon Biomedical Corp.

https://www.entheonbiomedical.com/

Entheon Biomedical Corp. is a biotechnology research and development company focused on creating therapeutic solutions for addiction and substance use disorders. The company specializes in the development and commercialization of psychedelic medicines, particularly dimethyltryptamine (DMT). Entheon aims to progress psychedelics to therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, and novel compounds tailored for treating these complex conditions.

Recent filings

Filing Released Lang Actions
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a completed Form 13-501F1 (Participation Fee) submitted to the Alberta Securities Commission, containing issuer certification and market value calculations. This is a regulatory form submission and does not match any more specific category (e.g., earnings release, M&A, management changes). Therefore it falls under the fallback category for general regulatory filings.
2025-03-05 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is Ontario Securities Commission Form 13-502F1 certifying the calculation and payment of the participation fee under OSC Rule 13-502 Fees. It is not an annual or interim financial report, earnings release, management presentation, or dividend/board change notice. Instead, it is a regulatory submission (fee payment form) to a securities regulator. Therefore, it falls under the general Regulatory Filings category (RNS).
2025-03-05 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 1% confidence The document is the Independent Auditors’ Report and accompanying Consolidated Financial Statements of Entheon Biomedical Corp. for the years ended November 30, 2024 and 2023. It contains the auditor’s opinion, basis for opinion, and full IFRS financial statements with notes. This is a standalone audit report and not a full annual report filing or an announcement. Therefore, it best fits the Audit Report / Information category (AR). FY 2024
2025-03-05 English
Material change report - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a Form 51-102F3 Material Change Report filed under Canadian NI 51-102. It announces the closing of a non-brokered private placement for gross proceeds of CA$500,000 and issuance of new units (equity + warrants). This is fundamentally a fundraising/capital structure update (private placement financing). It is not a simple announcement of a report (so not RPA), nor a share repurchase (POS) or threshold shareholding change (MRQ). Therefore, it falls under Capital/Financing Update (CAP).
2025-01-30 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is the full text of Form 45-106F1 “Report of Exempt Distribution,” a mandatory securities regulator filing (SEDAR+) detailing a distribution of securities under NI 45-106. It is not an annual or interim financial report, not an earnings release or investor presentation, and not merely an announcement of a report. It must be classified in the generic “Regulatory Filings” fallback category.
2025-01-09 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing an increase (upsizing) of a private placement financing, including details of units, warrants, proceeds, use of proceeds, and regulatory approvals. This is a capital-raising/financing update rather than a full financial report or regulatory filing. Therefore it fits the Capital/Financing Update category.
2024-12-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.